Page last updated: 2024-08-24

temoporfin and Actinic Reticuloid Syndrome

temoporfin has been researched along with Actinic Reticuloid Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexandratou, E; Kyriazi, M; Petri, A; Rallis, M; Roussis, V; Yova, D	1
Hopper, C; Kübler, A; Lewis, H; Putnam, G; Tan, IB	1
de Carpentier, J; Hopper, C; Kübler, AC; Leonard, AG; Putnam, G	1

Trials

2 trial(s) available for temoporfin and Actinic Reticuloid Syndrome

Article	Year
mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. International journal of cancer, 2004, Aug-10, Volume: 111, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Health Status; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pain; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Survival Analysis; Treatment Outcome	2004
Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy. International journal of oral and maxillofacial surgery, 2001, Volume: 30, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Injections, Intravenous; Laser Therapy; Lip Neoplasms; Lymphatic Metastasis; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Photosensitivity Disorders; Photosensitizing Agents; Prospective Studies; Radiation Dosage; Remission Induction; Safety; Treatment Outcome	2001

Article

Year

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

International journal of cancer, 2004, Aug-10, Volume: 111, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Health Status; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pain; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Survival Analysis; Treatment Outcome

2004

Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.

International journal of oral and maxillofacial surgery, 2001, Volume: 30, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Injections, Intravenous; Laser Therapy; Lip Neoplasms; Lymphatic Metastasis; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Photosensitivity Disorders; Photosensitizing Agents; Prospective Studies; Radiation Dosage; Remission Induction; Safety; Treatment Outcome

2001

Other Studies

1 other study(ies) available for temoporfin and Actinic Reticuloid Syndrome

Article	Year
Combination of Fospeg-IPDT and a natural antioxidant compound prevents photosensitivity in a murine prostate cancer tumour model. Photodiagnosis and photodynamic therapy, 2012, Volume: 9, Issue:2 Topics: Animals; Antioxidants; Biological Products; Cell Line, Tumor; Drug Carriers; Humans; Male; Mesoporphyrins; Mice; Mice, SCID; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Pinus; Plant Extracts; Polyethylene Glycols; Prostatic Neoplasms; Treatment Outcome	2012

Article

Year

Combination of Fospeg-IPDT and a natural antioxidant compound prevents photosensitivity in a murine prostate cancer tumour model.

Photodiagnosis and photodynamic therapy, 2012, Volume: 9, Issue:2

Topics: Animals; Antioxidants; Biological Products; Cell Line, Tumor; Drug Carriers; Humans; Male; Mesoporphyrins; Mice; Mice, SCID; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Pinus; Plant Extracts; Polyethylene Glycols; Prostatic Neoplasms; Treatment Outcome

2012